Related Experiment Video
Updated: Jun 16, 2026
09:07
Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
Published on: August 22, 2019
Accessing the human repertoire for broadly neutralizing HIV antibodies
1Theraclone Sciences, Seattle, WA, USA. phammond@theraclone-sciences.com
Mabs
|February 20, 2010
Summary
Developing an HIV vaccine relies on understanding protective human antibody responses. Researchers are identifying broadly neutralizing antibodies from infected individuals to guide vaccine design, focusing on methods to isolate these key antibodies.
Area of Science:
- Immunology
- Vaccinology
- Virology
Background:
- The development of a protective HIV vaccine is a critical global health priority.
- A subset of HIV-infected individuals naturally develop broadly neutralizing antibodies (bNAbs), offering insights into protective immunity.
- Understanding these bNAbs is crucial for designing effective HIV vaccines.
Purpose of the Study:
- To review and compare methods for isolating broadly neutralizing monoclonal HIV antibodies from infected individuals.
- To assess the efficiency and applicability of various antibody discovery techniques for HIV vaccine research.
Main Methods:
- Human hybridoma technology
- Epstein-Barr virus (EBV) transformation
- Non-immortalized B cell culture
- Clonal sorting
- Combinatorial antibody display
Main Results:
- Different methods vary in their efficiency for interrogating an individual's antibody repertoire.
- Assay formats (binding vs. biological) impact the screening process for desired antibodies.
- The ability to recover native antibody heavy and light chain pairs is a key consideration for method selection.
Conclusions:
- Identifying broadly neutralizing monoclonal HIV antibodies is essential for advancing HIV vaccine development.
- The choice of antibody isolation method impacts the success rate and characteristics of the generated antibodies.
- Further optimization of antibody discovery techniques is needed to facilitate the creation of a vaccine that elicits a similar protective immune response.
